Malignant melanoma associated with chronic once-daily aspirin exposure in males: A large, single-center, urban, US patient population cohort study from the “Research on Adverse Drug events And Report” (RADAR) project - 19/09/18

Kelsey A. Orrell, MB BCh BAO ^a, Ahuva D. Cices, MD ^a, Nicholas Guido, MD ^a, Sara Majewski, BS ^a, Erin Ibler, MD ^a, Thy Huynh, MD ^a, Stephanie M. Rangel, PhD ^a, Anne E. Laumann, MBBChB, MRCP (UK) ^a, Mary C. Martini, MD ^a, Alfred W. Rademaker, PhD ^{b, c}, Dennis P. West, PhD ^{a, c}, Beatrice Nardone, MD, PhD ^{a, ⁎}

^a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 

^b Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 

^c Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 

^∗Correspondence to: Beatrice Nardone, MD, PhD, Department of Dermatology, Northwestern University, 676 N Saint Clair St, Suite 1600, Chicago, IL 60611Department of DermatologyNorthwestern University676 N Saint Clair St, Suite 1600ChicagoIL60611